Hans Ovelgönne

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman et al. · Cytotherapy · 2020 · 67 citations · Full text

Engineering, Biomedical Engineering, Manufacturing Engineering +17

Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR

Johanna A.C. Schalk, Christa van den Elzen, Hans Ovelgönne et al. · Journal of Virological Methods · 2004 · 33 citations

Life Sciences, Immunology, Infectious Diseases +9

Estimation of manufacturing development costs of cell-based therapies: a feasibility study

Renske M.T. ten Ham, Julianne C. Nievaart, Jarno Hoekman et al. · Cytotherapy · 2021 · 27 citations · Full text

Engineering, Manufacturing Engineering, Pharmacoeconomics +16

Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective

Christian K. Schneider, Paula Salmikangas, Bernd Jilma et al. · The Lancet · 2010 · 12 citations

Engineering, Biotechnology, Regenerative Medicine +9